Various experimental models of ER+/PR+ breast cancer progression have been described in the literature and some are highlighted in this review, but most are not ideal for studying the role and mechanisms of steroid hormones and their cognate receptors in the transition of DCIS to IBC. This evidence concerns the gene PGR and ductal breast carcinoma in situ.